LEPR and metabolic dysfunction-associated steatotic liver disease: In addition to the blood glucose-lowering effects of metformin, histology of liver tissues showed that metformin could reduce hepatocyte diameter and body weight in Lepr WT rats with NAFLD phenotypes (Fig. 3A–C, E).